A milestone in_scientific_publishing_print_infographic(1)

The top 3 citation areas were: Drug-Drug Interactions (DDI): 33% PBPK Strategy/Regulatory: 11% Pediatrics: 11% Simcyp Consortium members have leveraged our products, the Simcyp Simulator, Simcyp Pediatric, and the Cardiac Safety Simulator, to support more than 50 publications in the last 2 years. For more information, visit www.certara.com © Copyright Certara 2015 IGO615-US-03 Our scientists have published papers using the Simcyp Simulator to study pharmacokinetics in virtual populations including: Pregnant Women Bariatric/Obese Patients Patients with Renal Impairment The top 3 areas we published in were: Pediatrics: 33% Biologics: 17% Cardiac Safety: 17% A Milestone in Scientiﬁc Publishing We hit a landmark in scientiﬁc contributions for Physiologically Based Pharmacokinetic (PBPK) modeling and simulation: 100+ papers published over the past eight years!

Upload
certara
Category

Health & Medicine
view
11
download
0

Embed Size (px):

Transcript of A milestone in_scientific_publishing_print_infographic(1)

Page 1: A milestone in_scientific_publishing_print_infographic(1)

The top 3 citation areas were:

Drug-Drug Interactions (DDI): 33%

PBPK Strategy/Regulatory: 11%

Pediatrics: 11%

Simcyp Consortium members have leveraged our products, the Simcyp Simulator, Simcyp Pediatric, and the Cardiac Safety Simulator, to support more than 50 publications in the last 2 years.

For more information, visit www.certara.com© Copyright Certara 2015IGO615-US-03

Our scientists have published papers using the Simcyp Simulator to study pharmacokinetics in

virtual populations including:

PregnantWomen

Bariatric/Obese Patients

Patients withRenal Impairment

The top 3 areas we published in were:

Pediatrics: 33%

Biologics: 17%

Cardiac Safety: 17%

A Milestone in Scientific Publishing

We hit a landmark in scientific contributions for Physiologically Based Pharmacokinetic (PBPK) modeling and simulation: 100+ papers published over the past eight years!